Dynamic HER2-low status among patients with triple negative breast cancer (TNBC): The impact of repeat biopsies

被引：0
|
作者：
Bar, Yael
Dedeoglu, Aylin S.
Fell, Geoffrey G.
Moffett, Natalie J.
Boyraz, Baris
Ly, Amy
Bardia, Aditya
Moy, Beverly
Ellisen, Leif W.
Isakoff, Steven J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1005
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical and Molecular Characteristics of HER2-low/zero Early Stage Triple-Negative Breast Cancer
    Yam, Clinton
    Li, Ziyi
    Korkut, Anil
    Ma, Wencai
    Kong, Elisabeth
    Hill, Holly A.
    Abbas, Hussein
    Abouharb, Sausan
    Adrada, Beatriz
    Arun, Banu K.
    Barcenas, Carlos H.
    Bisen, Ajit
    Booser, Daniel
    Buzdar, Aman
    Candelaria, Rosalind
    Chen, Junjie
    Clayborn, Alyson
    Damodaran, Senthil
    Ding, Qingqing
    Garber, Haven
    Hortobagyi, Gabriel N.
    Hunt, Kelly K.
    Ibrahim, Nuhad K.
    Iheme, Adaeze
    Karuturi, Meghan S.
    Koenig, Kimberly
    Layman, Rachel M.
    Lee, Jangsoon
    Litton, Jennifer K.
    Mitchell, Melissa
    Moscol, Giancarlo
    Mouabbi, Jason
    Murthy, Rashmi K.
    Oke, Oluchi
    Pohlmann, Paula
    Ramirez, David
    Ravenberg, Elizabeth
    Saleem, Sadia
    Teshome, Mediget
    Valero, Vicente
    White, Jason
    Williams, Madison
    Woodward, Wendy
    Yajima, Chasity
    Ueno, Naoto T.
    Chen, Ken
    Rauch, Gaiane
    Huo, Lei
    Tripathy, Debu
    CANCER RESEARCH, 2023, 83 (05)
  • [32] Heterogeneity and prognostic characteristics of HER2-low breast cancer: A retrospective analysis of patients with HER2-negative metastatic breast cancer
    Lv, Huimin
    Yan, Min
    Zhang, Mengwei
    Niu, Limin
    Zeng, Huiai
    Sun, Huihui
    Zhao, Shengnan
    Wang, Jing
    CANCER RESEARCH, 2024, 84 (09)
  • [33] Characterization of Circulating Tumor Cell-HER2 Status in Patients with HER2-Low Invasive Breast Cancer
    Chen, Jennifer H.
    Meas, Salyna
    Sarli, Vanessa N.
    Koupaei, Negar
    Upshaw, Joshua
    Lucci, Anthony, Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S49 - S49
  • [34] Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status
    Raghavendra, A. S.
    Zakon, D. B.
    Jin, Q.
    Strahan, A.
    Grimm, M.
    Hughes, M. E.
    Cherian, M.
    Vincuilla, J.
    Parker, T.
    Tarantino, P.
    Mittendorf, E. A.
    King, T. A.
    Valero, V.
    Tripathy, D.
    Tolaney, S. M.
    Tayob, N.
    Lin, N. U.
    Stover, D. G.
    Barcenas, C. H.
    Garrido-Castro, A. C.
    ESMO OPEN, 2024, 9 (11)
  • [35] Characteristics and clinical outcomes of patients with HER2-low breast cancer
    Koh, S.
    Koi, Y.
    Tajiri, W.
    Kawasaki, J.
    Akiyoshi, S.
    Nakamura, Y.
    Koga, C.
    Tokunaga, E.
    BREAST, 2023, 68 : S32 - S32
  • [36] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    BMC Cancer, 23 (1)
  • [37] Clinical outcomes in early-stage TNBC according to HER2-low status
    Garrido-Castro, Ana
    Zakon, Danielle Brandes
    Jin, Qingchun
    Grimm, Michael
    Raghavendra, Akshara Singareeka
    Hughes, Melissa
    Cherian, Mathew
    Vincuilla, Julie
    Parker, Tonia
    Tarantino, Paolo
    Mittendorf, Elizabeth
    King, Tari
    Valero, Vicente
    Tripathy, Debu
    Ramaswamy, Bhuvaneswari
    Tolaney, Sara
    Tayob, Nabihah
    Lin, Nancy
    Stover, Daniel
    Barcenas, Carlos
    CANCER RESEARCH, 2024, 84 (09)
  • [38] BIOMARKER IDENTIFICATION IN TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS
    Mohan, Kabhilan
    Shih, Andrew
    Liew, Anthony
    Khalili, Houman
    Sultan, Gwyneth
    Shapira, Iuliana
    Lee, Annette
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (04) : 920 - 920
  • [39] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Yang, Xin
    Li, Yao
    Lu, Xu
    Ren, Xiaotian
    Hua, Bin
    BMC CANCER, 2023, 23 (01)
  • [40] The effect of eribulin treatment for patients with HER2-low breast cancer
    Goto, Wataru
    Henmi, Saeko
    Nishikawa, Mariko
    Kouchi, Asuka
    Kouhashi, Rika
    Yabumoto, Akimichi
    Takada, Koji
    Asano, Yuka
    Tauchi, Yukie
    Ogisawa, Kana
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    CANCER RESEARCH, 2024, 84 (09)
12345